Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Biotech beauty, the most common co-covered peer. Biodance appears in 1 tracked Biotech story from August 12, 2026. The tracked stories average 2 original sources each.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Biodance
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Biotech beauty, the most common co-covered peer. Biodance appears in 1 tracked Biotech story from August 12, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 11 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Biodance. Shared-story counts are live from our verified record — not editorial picks.
Biotech beauty leverages fermentation and living microorganisms to create products that bridge the gap between cosmetics and therapeutics. This has deep implications for drug delivery approaches, regulatory classification, and potential pharma partnerships as startups apply wound-healing science to everyday skincare.